• LC–MS/MS Mapping of GS-441524 Prodrug Conversion Pathways

  2026-05-01

  This study establishes a validated LC–MS/MS protocol to elucidate the in vitro and in vivo conversion dynamics of a novel GS-441524 prodrug (NGP-1) and its active metabolite. The findings clarify the absorption and bioactivation routes, supporting informed development of orally bioavailable antiviral nucleoside analogs.

• RITA (NSC 652287): Optimizing Tumor Xenograft and Apoptosis

  2026-05-01

  RITA (NSC 652287) stands at the forefront of MDM2-p53 interaction inhibitors, enabling precise modulation of p53 pathways in cancer biology. This guide delivers actionable workflows for apoptosis assays and tumor xenograft models, grounded in data-driven insight and practical troubleshooting for renal carcinoma research.

• Strategic Deployment of SAG for Hedgehog Pathway Translation

  2026-04-30

  This thought-leadership article unpacks the mechanistic underpinnings and translational strategy for Smoothened Agonist (SAG), with a focus on its role as a selective Hedgehog (Hh) signaling pathway activator. Integrating primary literature, protocol optimization, and competitive analysis, we provide actionable guidance for researchers leveraging SAG in disease modeling and regenerative biology. The discussion bridges experimental rigor with clinical foresight, setting new benchmarks beyond standard product communications.

• FLAG tag Peptide (DYKDDDDK): Biophysical Precision and Workf

  2026-04-30

  Discover the advanced biophysical properties of the FLAG tag Peptide (DYKDDDDK) and its strategic role in recombinant protein detection and purification. This article provides a unique, evidence-based perspective on protocol optimization and assay design.

• Structural Basis for HCAR3 Agonist Selectivity in Lipid Meta

  2026-04-29

  This study provides high-resolution cryo-EM structures of HCAR3 and HCAR2 in complex with selective agonists, including (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid (Acifran). The findings clarify the molecular determinants of ligand recognition and selectivity, guiding development of hypolipidemic agents for precise lipid metabolism research.

• Vidarabine Monohydrate: Antiviral Mechanism & Research Workf

  2026-04-29

  Vidarabine monohydrate, a high-purity nucleoside analog from APExBIO, is engineered for advanced inhibition of viral DNA synthesis in virology research. This article delivers actionable workflows, troubleshooting strategies, and data-backed parameters to maximize its impact in herpes simplex virus and DNA replication interference models.

• SD 169 (indole-5-carboxamide): Optimizing p38 MAPK Pathway A

  2026-04-28

  SD 169 (indole-5-carboxamide) empowers researchers with selective, reproducible inhibition of p38α/β MAP kinases for advanced inflammation and neuroregeneration workflows. Explore evidence-driven protocol enhancements, troubleshooting strategies, and novel dual-action mechanisms validated by cutting-edge structural biology.

• Artesunate: Optimizing In Vitro Cancer Research Workflows

  2026-04-28

  Artesunate, a potent artemisinin derivative, delivers unique mechanistic advantages for in vitro cancer assays by modulating cell death pathways and AKT/mTOR signaling. This article translates recent scholarly advances and practical workflow insights into actionable guidance, setting new standards for reproducibility and discovery in oncology research.

• FLNa-Mediated NF-κB Pathway Blockade Fuels HEV Replication

  2026-04-27

  This study identifies filamin A (FLNa) as a crucial cytoskeletal regulator whose inhibition promotes hepatitis E virus (HEV) replication by suppressing the NF-κB signaling pathway. The findings illuminate new mechanistic links between cytoskeleton remodeling, innate immunity evasion, and viral propagation, with implications for infection control and pathway-targeted research.

• LGK-974: Potent PORCN Inhibitor for Wnt Pathway Research

  2026-04-27

  LGK-974 is a highly specific PORCN inhibitor that blocks Wnt secretion at nanomolar potency. It demonstrates robust anti-tumor efficacy in Wnt-dependent cancer models, including those with RNF43 mutations. This article details LGK-974’s mechanism, benchmarks, and best practices for experimental integration.

• Z-WEHD-FMK: Optimizing Caspase Pathway Assays in Inflammatio

  2026-04-26

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) is a benchmark irreversible caspase inhibitor enabling precise dissection of inflammatory and apoptotic signaling in cellular models. This guide translates the latest reference findings and validated protocols into actionable workflows, troubleshooting tips, and advanced applications for maximizing assay reproducibility in inflammation and infectious disease research.

• DiscoveryProbe FDA-approved Drug Library: Precision in Cance

  2026-04-25

  The DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) transforms high-throughput screening workflows by offering 2,320 pre-dissolved clinical compounds for rapid drug repositioning and pharmacological target identification. This library is uniquely suited for translational cancer research, enabling discovery of synergistic drug combinations and mechanism-driven therapeutic strategies.

• Cytoskeleton Dependence of Mechanical Stress-Induced Autopha

  2026-04-24

  This study demonstrates that the induction of autophagy by mechanical compression in human cell lines is critically dependent on the cytoskeleton, especially microfilaments. Microtubules play an auxiliary role, highlighting the cytoskeleton’s central function in mechanotransduction and autophagic signaling, with implications for dissecting calcium signaling pathways and mechanical stress responses.

• Pemetrexed Disodium: Advanced Workflows in Tumor Cell Resear

  2026-04-24

  Pemetrexed disodium is redefining cancer chemotherapy research through its multi-targeted inhibition of folate-dependent pathways. This guide delivers actionable protocols, troubleshooting insights, and translational strategies for leveraging pemetrexed in tumor biology, with a focus on mesothelioma and non-small cell lung carcinoma.

• Ginsenoside Rb1 Protects Against Cerebral Ischemia via Wnt/β

  2026-04-23

  Liu et al. (2025) demonstrate that ginsenoside Rb1 alleviates neuroinflammation and improves neurological outcomes in a mouse model of cerebral ischemia-reperfusion injury by activating the Wnt/β-catenin signaling pathway. Their use of XAV-939 to mechanistically verify pathway involvement highlights the importance of precise pathway modulation tools in neuroprotection research.

15798 records 1/1054 page Next 12345 下5页 Last page